Table of Content
- Global Newborn Genetic Testing Market Introduction and Market Overview
1.1. Objective of the Study
1.2. Global Newborn Genetic Testing Market Scope and Market Estimation
1.2.1. Global Newborn Genetic Testing Overall Market Size (US$ Mn), Market CAGR (%), Market Forecast (2022-2030)
1.2.2. Global Newborn Genetic Testing Market Revenue Share (%) and Growth Rate (Y-o-Y) from 2022-2030
1.3. Market Segmentation
1.3.1. Diagnostic of Global Newborn Genetic Testing Market
1.3.2. Disease of Global Newborn Genetic Testing Market
1.3.3. End User of Global Newborn Genetic Testing Market
1.3.4. Region of Global Newborn Genetic Testing Market
- Global Newborn Genetic Testing Market - Executive Summary
2.1. Key Findings
2.1.1. Top Impacting Factors
2.1.2. Top Investment Pockets
2.1.3. Market Attractiveness Analysis
2.2. Key Companies Introduction
- Market Factor Analysis
3.1. Global Newborn Genetic Testing Market Industry Development Trends under COVID-19 Outbreak
3.1.1. Global COVID-19 Status Overview
3.1.2. Influence of COVID-19 Outbreak on Global Newborn Genetic Testing Market Industry Development
3.2. Market Dynamics (Growth Influencers)
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.2.4. Impact Analysis of Drivers and Restraints
3.3. Ecosystem/ Value Chain Analysis
3.4. Porter’s Five Forces Analysis
3.5. SWOT Analysis
3.6. PEST Analysis
3.7. Market Opportunity Assessment – by Region (North America/ Europe/ Asia Pacific/ Middle East and Africa/ South America)
3.7.1. By Diagnostic
3.7.2. By Disease
3.7.3. By End User
- Global Newborn Genetic Testing Market: Estimates & Historical Trend Analysis (2017-2020)
- Global Newborn Genetic Testing Market Estimates & Forecast Trend Analysis by Diagnostic
5.1. Newborn Genetic Testing Market Share (%) Estimates and Forecasts, by Diagnostic, 2022 & 2030
5.1.1. Key Market Trends, Growth Factors, and Opportunities
5.2. Newborn Genetic Testing Market Revenue (US$ Mn) Estimates and Forecasts, by Diagnostic, 2017 to 2030
5.2.1. Key Market Trends, Growth Factors, and Opportunities
5.3. Spectrophotometer
5.4. Polymerase Chain Reaction
5.5. Fluorescence in-situ Hybridization
5.6. Array-Comparative Genomic Hybridization
5.7. Screening
5.8. Maternal Serum Screening
5.9. Chronic Villus Sampling
5.10. Amniocentesis
5.11. Non-invasive Prenatal Testing
- Global Newborn Genetic Testing Market Estimates & Forecast Trend Analysis by Disease
6.1. Newborn Genetic Testing Market Share (%) Estimates and Forecasts, by Disease, 2022 & 2030
6.1.1. Key Market Trends, Growth Factors, and Opportunities
6.2. Newborn Genetic Testing Market Revenue (US$ Mn) Estimates and Forecasts, by Disease, 2017 to 2030
6.2.1. Key Market Trends, Growth Factors, and Opportunities
6.3. Cystic Fibrosis
6.4. Sickle Cell Anemia
6.5. Down Syndrome
6.6. Phenylketonuria
6.7. Others
- Global Newborn Genetic Testing Market Estimates & Forecast Trend Analysis, by End User
7.1. Newborn Genetic Testing Market Share (%) Estimates and Forecasts, by End User, 2022 & 2030
7.1.1. Key Market Trends, Growth Factors, and Opportunities
7.2. Newborn Genetic Testing Market Revenue (US$ Mn) Estimates and Forecasts, by End User, 2017 to 2030
7.2.1. Key Market Trends, Growth Factors, and Opportunities
7.3. Hospitals & Clinics
7.4. Diagnostic Centers
7.5. Others
- Global Newborn Genetic Testing Market Analysis and Forecast, by Region
8.1. Newborn Genetic Testing Market Share (%) Estimates and Forecasts, by Region, 2022 & 2030
8.1.1. Key Market Trends, Growth Factors, and Opportunities
8.2. Newborn Genetic Testing Market Revenue (US$ Mn) Estimates and Forecasts, by Region, 2017 to 2030
8.2.1. Key Market Trends, Growth Factors, and Opportunities
8.2.2. North America
8.2.3. Europe
8.2.4. Asia Pacific
8.2.5. Middle East and Africa
8.2.6. South America
- North America Newborn Genetic Testing Market: Estimates & Forecast Trend Analysis
9.1. North America Market Assessments & Key Findings
9.2. North America Newborn Genetic Testing Market Share (%) Estimates and Forecasts, 2022 & 2030
9.3. North America Newborn Genetic Testing Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
9.3.1. By Diagnostic
9.3.2. By Disease
9.3.3. By End User
9.3.4. By Country
9.3.4.1. U.S.
9.3.4.2. Canada
9.3.4.3. Mexico
- Europe Newborn Genetic Testing Market: Estimates & Forecast Trend Analysis
10.1. Europe Market Assessments & Key Findings
10.2. Europe Newborn Genetic Testing Market Share (%) Estimates and Forecasts, 2022 & 2030
10.3. Europe Newborn Genetic Testing Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
10.3.1. By Diagnostic
10.3.2. By Disease
10.3.3. By End User
10.3.4. By Country
10.3.4.1. Germany
10.3.4.2. U.K.
10.3.4.3. France
10.3.4.4. Italy
10.3.4.5. Spain
10.3.4.6. Russia
10.3.4.7. Rest of Europe
- Asia Pacific Newborn Genetic Testing Market: Estimates & Forecast Trend Analysis
11.1. Asia Pacific Market Assessments & Key Findings
11.2. Asia Pacific Newborn Genetic Testing Market Share (%) Estimates and Forecasts, 2022 & 2030
11.3. Asia Pacific Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
11.3.1. By Diagnostic
11.3.2.By Disease
11.3.3. By End User
11.3.4. By Country
11.3.4.1. China
11.3.4.2. Japan
11.3.4.3. India
11.3.4.4. Australia
11.3.4.5. South Korea
11.3.4.6. Rest of Asia Pacific
- Middle East & Africa Newborn Genetic Testing Market: Estimates & Forecast Trend Analysis
12.1. Middle East & Africa Market Assessments & Key Findings
12.2. Middle East & Africa Newborn Genetic Testing Market Share (%) Estimates and Forecasts, 2022 & 2030
12.3. Middle East & Africa Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
12.3.1.By Diagnostic
12.3.2. By Disease
12.3.3. By End User
12.3.4. By Country
12.3.4.1. U.A.E.
12.3.4.2. Saudi Arabia
12.3.4.3. Egypt
12.3.4.4. South Africa
12.3.4.5. Rest of Middle East & Africa
- South America Newborn Genetic Testing Market: Estimates & Forecast Trend Analysis
13.1. South America Market Assessments & Key Findings
13.2. South America Newborn Genetic Testing Market Share (%) Estimates and Forecasts, 2022 & 2030
13.3. South America Market Size Estimates and Forecast (US$ Million) (2017 to 2030)
13.3.1. By Diagnostic
13.3.2. By Disease
13.3.3. By End User
13.3.4. By Country
13.3.4.1. Brazil
13.3.4.2. Argentina
13.3.4.3. Colombia
13.3.4.4. Rest of South America
- Manufacturing Cost Structure Analysis
14.1. Raw Material and Suppliers
14.2. Manufacturing Cost Structure Analysis of Newborn Genetic Testing
14.3. Manufacturing Process Analysis of Newborn Genetic Testing
14.4. Industry Chain Structure of Newborn Genetic Testing
- Marketing, Distributors and Customer
15.1. Sales Channel
15.1.1. Direct Channels
15.1.2. Indirect Channels
15.2. Newborn Genetic Testing Distributors
15.3. Newborn Genetic Testing Customer
- Competition Landscape
16.1. Key Manufacturers Newborn Genetic Testing Producing Area Distribution, Sales Area, Disease Capacity
16.2. Key Manufacturers Newborn Genetic Testing Disease Location Distribution
16.3. Market Competition Matrix, by Leading Players
16.3.1.Competition Landscape Analysis
16.3.2. Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
16.4. List of Emerging, Prominent and Leading Players
16.5. Major Mergers & Acquisitions, Partnership, Joint Venture, Expansions, Deals, Etc.
- Company Profiles
17.1. Ariosa Diagnostics (Roche)
17.1.1. Company Information
17.1.2.Newborn Genetic Testing Disease Offered
17.1.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.1.4. Main Business Overview
17.1.5. Latest Developments
17.2. Berry Genomics
17.2.1. Company Information
17.2.2. Newborn Genetic Testing Disease Offered
17.2.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.2.4. Main Business Overview
17.2.5. Latest Developments
17.3. BGI
17.3.1. Company Information
17.3.2. Newborn Genetic Testing Disease Offered
17.3.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.3.4. Main Business Overview
17.3.5. Latest Developments
17.4. Bio-Rad Laboratories Inc.
17.4.1. Company Information
17.4.2. Newborn Genetic Testing Disease Offered
17.4.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.4.4. Main Business Overview
17.4.5. Latest Developments
17.5. Illumina
17.5.1. Company Information
17.5.2. Newborn Genetic Testing Disease Offered
17.5.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.5.4. Main Business Overview
17.5.5. Latest Developments
17.6. Laboratory Corporation of America
17.6.1. Company Information
17.6.2. Newborn Genetic Testing Disease Offered
17.6.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.6.4. Main Business Overview
17.6.5. Latest Developments
17.7. Natera
17.7.1. Company Information
17.7.2. Newborn Genetic Testing Disease Offered
17.7.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.7.4. Main Business Overview
17.7.5. Latest Developments
17.8. Qiagen
17.8.1. Company Information
17.8.2. Newborn Genetic Testing Disease Offered
17.8.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.8.4. Main Business Overview
17.8.5. Latest Developments
17.9. Sequenom
17.9.1. Company Information
17.9.2. Newborn Genetic Testing Disease Offered
17.9.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.9.4. Main Business Overview
17.9.5. Latest Developments
17.10. Trivitron Healthcare
17.10.1. Company Information
17.10.2. Newborn Genetic Testing Disease Offered
17.10.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.10.4. Main Business Overview
17.10.5. Latest Developments
17.11. Verinata Health
17.11.1. Company Information
17.11.2. Newborn Genetic Testing Disease Offered
17.11.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.11.4. Main Business Overview
17.11.5. Latest Developments
17.12. Agilent Technologies Inc.
17.12.1. Company Information
17.12.2. Newborn Genetic Testing Disease Offered
17.12.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.12.4. Main Business Overview
17.12.5. Latest Developments
17.13. Quest Diagnostics Incorporated
17.13.1. Company Information
17.13.2. Newborn Genetic Testing Disease Offered
17.13.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.13.4. Main Business Overview
17.13.5. Latest Developments
17.14. F. Hoffmann La-Roche Ltd.
17.14.1. Company Information
17.14.2. Newborn Genetic Testing Disease Offered
17.14.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.14.4. Main Business Overview
17.14.5. Latest Developments
17.15. PerkinElmer, Inc.
17.15.1. Company Information
17.15.2. Newborn Genetic Testing Disease Offered
17.15.3. Newborn Genetic Testing Sales, Revenue, Price, and Gross Margin (2018-2022)
17.15.4. Main Business Overview
17.15.5. Latest Developments
- Assumptions and Research Methodology
- Conclusions and Recommendations
19.1. Analysis and Suggestions on New Project Investment
19.2. Research Findings and Conclusion
List of Tables
Table1 Global Newborn Genetic Testing Market Historical Analysis (US$ Mn), 2017-2021
Table2 Global Newborn Genetic Testing Market Forecast Opportunity Analysis (US$ Mn), 2022-2030
Table3 Global Newborn Genetic Testing Market Absolute $ Opportunity
Table4 Global Newborn Genetic Testing Market Analysis by Diagnostic, 2017-2030
Table5 Global Newborn Genetic Testing Market Analysis by Disease, 2017-2030
Table6 Global Newborn Genetic Testing Market Analysis by End User, 2017-2030
Table7 Global Newborn Genetic Testing Market Analysis by Region, 2017-2030
Table8 North America Newborn Genetic Testing Market Absolute $ Opportunity
Table9 North America Newborn Genetic Testing Market Analysis by Diagnostic, 2017-2030
Table10 North America Newborn Genetic Testing Market Analysis by Disease, 2017-2030
Table11 North America Newborn Genetic Testing Market Analysis by End User, 2017-2030
Table12 North America Newborn Genetic Testing Market Analysis by Country, 2017-2030
Table13 South America Newborn Genetic Testing Market Absolute $ Opportunity
Table14 South America Newborn Genetic Testing Market Analysis by Diagnostic, 2017-2030
Table15 South America Newborn Genetic Testing Market Analysis by Disease, 2017-2030
Table16 South America Newborn Genetic Testing Market Analysis by End User, 2017-2030
Table17 South America Newborn Genetic Testing Market Analysis by Country, 2017-2030
Table18 Europe Newborn Genetic Testing Market Absolute $ Opportunity
Table19 Europe Newborn Genetic Testing Market Analysis by Diagnostic, 2017-2030
Table20 Europe Newborn Genetic Testing Market Analysis by Disease, 2017-2030
Table21 Europe Newborn Genetic Testing Market Analysis by End User, 2017-2030
Table22 Europe Newborn Genetic Testing Market Analysis by Country, 2017-2030
Table23 Asia Pacific Newborn Genetic Testing Market Absolute $ Opportunity
Table24 Asia Pacific Newborn Genetic Testing Market Analysis by Diagnostic, 2017-2030
Table25 Asia Pacific Newborn Genetic Testing Market Analysis by Disease, 2017-2030
Table26 Asia Pacific Newborn Genetic Testing Market Analysis by End User, 2017-2030
Table27 Asia Pacific Newborn Genetic Testing Market Analysis by Country, 2017-2030
Table28 MEA Newborn Genetic Testing Market Absolute $ Opportunity
Table29 MEA Newborn Genetic Testing Market Analysis by Diagnostic, 2017-2030
Table30 MEA Newborn Genetic Testing Market Analysis by Disease, 2017-2030
Table31 MEA Newborn Genetic Testing Market Analysis by End User, 2017-2030
Table32 MEA Newborn Genetic Testing Market Analysis by Country, 2017-2030
List of Figures
Figure1 Global Newborn Genetic Testing Market Historic Y-o-Y Analysis (%), 2017-2021
Figure2 Global Newborn Genetic Testing Market Forecast Y-o-Y Analysis (%), 2022-2030
Figure3 Global Newborn Genetic Testing Market Share Analysis by Diagnostic, 2021 and 2030
Figure4 Global Newborn Genetic Testing Market Share Analysis by Disease, 2021 and 2030
Figure5 Global Newborn Genetic Testing Market Share Analysis by End User, 2021 and 2030
Figure6 Global Newborn Genetic Testing Market Share Analysis by Region, 2021 and 2030
Figure7 North America Newborn Genetic Testing Market Share Analysis by Diagnostic, 2021 and 2030
Figure8 North America Newborn Genetic Testing Market Share Analysis by Disease, 2021 and 2030
Figure9 North America Newborn Genetic Testing Market Share Analysis by End User, 2021 and 2030
Figure10 North America Newborn Genetic Testing Market Share Analysis by Country, 2021 and 2030
Figure11 South America Newborn Genetic Testing Market Share Analysis by Diagnostic, 2021 and 2030
Figure12 South America Newborn Genetic Testing Market Share Analysis by Disease, 2021 and 2030
Figure13 South America Newborn Genetic Testing Market Share Analysis by End User, 2021 and 2030
Figure14 South America Newborn Genetic Testing Market Share Analysis by Country, 2021 and 2030
Figure15 Europe Newborn Genetic Testing Market Share Analysis by Diagnostic, 2021 and 2030
Figure16 Europe Newborn Genetic Testing Market Share Analysis by Disease, 2021 and 2030
Figure17 Europe Newborn Genetic Testing Market Share Analysis by End User, 2021 and 2030
Figure18 Europe Newborn Genetic Testing Market Share Analysis by Country, 2021 and 2030
Figure19 Asia Pacific Newborn Genetic Testing Market Share Analysis by Diagnostic, 2021 and 2030
Figure20 Asia Pacific Newborn Genetic Testing Market Share Analysis by Disease, 2021 and 2030
Figure21 Asia Pacific Newborn Genetic Testing Market Share Analysis by End User, 2021 and 2030
Figure22 Asia Pacific Newborn Genetic Testing Market Share Analysis by Country, 2021 and 2030
Figure23 MEA Newborn Genetic Testing Market Share Analysis by Diagnostic, 2021 and 2030
Figure24 MEA Newborn Genetic Testing Market Share Analysis by Disease, 2021 and 2030
Figure25 MEA Newborn Genetic Testing Market Share Analysis by End User, 2021 and 2030
Figure26 MEA Newborn Genetic Testing Market Share Analysis by Country, 2021 and 2030
